EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving Parkinson’s disease management through wearable technology: A cost-benefit perspective

Daniel Rodriguez-Martin, Andreu Català iD, Joan Cabestany

PLOS One · 2025

DOI: 10.1371/journal.pone.0334413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Daniel Rodriguez-Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sense4Care S.L., Cornellà de Llobregat, Spain. Hauptthemen laut MEDLINE: Parkinson Disease, Wearable Electronic Devices, Cost-Benefit Analysis. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s Disease (PD) is a progressive neurodegenerative disorder affecting millions of patients worldwide, with significant economic and social implications. The increasing prevalence of PD, coupled with rising healthcare costs, necessitates cost-effective solutions for patient management. Wearable medical devices, such as STAT-ON™, an inertial sensor with AI processing capability, offer an opportunity to enhance symptom monitoring, optimize therapy adjustments, and improve patient quality of life (QoL). However, their cost-effectiveness in routine clinical practice remains insufficiently explored. This study conducts a cost-benefit analysis of integrating STAT-ON™ into European healthcare systems (Spain, Sweden, Germany, Italy, and the UK). Using validated clinical data, we assess the economic impact of early symptom detection facilitated by continuous monitoring. Our findings suggest that improved symptom assessment can lead to optimized medication regimens, reducing hospitalizations and institutional care costs. While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. As an example, the study estimates potential cost reductions of up to €137.8 million in Germany and €19 million in Sweden when STAT-ON™ is used to detect advanced PD symptoms. Despite these promising results, limitations exist, including variations in healthcare costs, reimbursement policies, and real-world adoption rates across the different countries. Additionally, indirect costs such as caregiver burden were not fully analyzed. Future longitudinal studies are needed to further validate the economic and clinical benefits of wearable monitoring devices in PD management. This study highlights the potential of STAT-ON™ as a valuable tool for reducing healthcare costs and enhancing patient outcomes, supporting its adoption as a complementary solution for objective PD assessment in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseWearable Electronic DevicesCost-Benefit AnalysisHumansQuality of LifeHealth Care CostsMaleFemaleAgedEuropeMiddle AgedDisease Management

Autor:innen und Institutionen

  • Sense4Care S.L., Cornellà de Llobregat, Spain.
  • Universitat Politècnica de Catalunya, Vilanova I la Geltrú, Spain.

ORCID-Profile: Andreu Català

Zitieren

APA

Rodriguez-Martin, D., Català, A., & Cabestany, J. (2025). Improving Parkinson’s disease management through wearable technology: A cost-benefit perspective. PLOS One. https://doi.org/10.1371/journal.pone.0334413

Vancouver

Rodriguez-Martin D, Català A, Cabestany J. Improving Parkinson’s disease management through wearable technology: A cost-benefit perspective. PLOS One. 2025. doi:10.1371/journal.pone.0334413

BibTeX
@article{RodriguezMartin2025,
  author = {Rodriguez-Martin, Daniel and Català, Andreu and Cabestany, Joan},
  title = {Improving Parkinson’s disease management through wearable technology: A cost-benefit perspective},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0334413}
}
Kostenlos starten →